Showing results (31-40 of 197) with videos related to
Sort By:
Pageof 20
International Journal of Molecular Sciences|October 14, 2022
Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer ImmunotherapySabina Sánchez Hernández, Martin Roelsgaard Jakobsen, Rasmus O BakBiomedicines|October 27, 2022
Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AMLMaya Graham Pedersen, Bjarne Kuno Møller, Rasmus O BakMolecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2015
Genome editing of the germline: broadening the discussionMatthew H Porteus, Christina T DannImmunological Reviews|January 18, 2024
Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacyHana Y Ghanim, Matthew H PorteusExperimental Dermatology|March 3, 2012
Lentiviral vectors for cutaneous RNA managingMaria Nascimento Primo, Rasmus O Bak, Jacob Giehm MikkelsenNature Medicine|August 8, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsChristopher A Vakulskas, Daniel P Dever, Garrett R Rettig, et al.Science Translational Medicine|June 17, 2021
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell diseaseAnnalisa Lattanzi, Joab Camarena, Premanjali Lahiri, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Managing microRNAs with vector-encoded decoy-type inhibitorsRasmus O Bak, Anne Kruse Hollensen, Jacob Giehm MikkelsenFrontiers in Genome Editing|April 4, 2022
CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency SyndromeSujan Ravendran, Sabina Sánchez Hernández, Saskia König, et al.Molecular Pharmacology|February 8, 2012
The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cellsDaniel P Dever, Lisa A OpanashukPageof 20